Alps Advisors Inc Vericel Corp Transaction History

Alps Advisors Inc

$14.8 Billion
Q3 2024

A detailed history of Alps Advisors Inc transactions in Vericel Corp stock. As of the latest transaction made, Alps Advisors Inc holds 37,087 shares of VCEL stock, worth $2.19 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

37,087

Previous 37,905 2.16%

Holding current value

$2.19 Million

Previous $1.74 Million 9.95%

% of portfolio

0.01%

Previous 0.01%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$42.25 - $53.56 $34,560 - $43,812	-818 Reduced 2.16%	37,087 $1.57 Million
Q2 2024 Aug 13, 2024	BUY	$41.71 - $52.9 $160,208 - $203,188	3,841 Added 11.28%	37,905 $1.74 Million
Q1 2024 May 14, 2024	BUY	$32.52 - $52.33 $49,235 - $79,227	1,514 Added 4.65%	34,064 $1.77 Million
Q4 2023 Feb 14, 2024	SELL	$30.85 - $37.09 $81,320 - $97,769	-2,636 Reduced 7.49%	32,550 $1.16 Million
Q3 2023 Nov 14, 2023	BUY	$31.69 - $39.25 $7,130 - $8,831	225 Added 0.64%	35,186 $1.18 Million
Q2 2023 Aug 14, 2023	BUY	$29.0 - $38.37 $108,924 - $144,117	3,756 Added 12.04%	34,961 $1.31 Million
Q1 2023 May 10, 2023	SELL	$23.85 - $31.34 $19,199 - $25,228	-805 Reduced 2.51%	31,205 $914,000
Q4 2022 Feb 14, 2023	BUY	$17.65 - $27.37 $110,259 - $170,980	6,247 Added 24.25%	32,010 $843,000
Q3 2022 Nov 14, 2022	SELL	$22.62 - $32.54 $49,583 - $71,327	-2,192 Reduced 7.84%	25,763 $598,000
Q2 2022 Aug 11, 2022	BUY	$22.88 - $39.45 $639,610 - $1.1 Million	27,955 New	27,955 $704,000
Q4 2021 Feb 09, 2022	SELL	$35.2 - $52.6 $2.01 Million - $3.01 Million	-57,152 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$46.35 - $59.75 $167,045 - $215,339	-3,604 Reduced 5.93%	57,152 $2.79 Million
Q2 2021 Aug 11, 2021	SELL	$47.2 - $67.81 $1.06 Million - $1.52 Million	-22,387 Reduced 26.93%	60,756 $3.19 Million
Q1 2021 May 07, 2021	BUY	$30.93 - $59.48 $41,848 - $80,476	1,353 Added 1.65%	83,143 $4.62 Million
Q4 2020 Feb 03, 2021	BUY	$18.53 - $31.5 $446,369 - $758,803	24,089 Added 41.75%	81,790 $2.53 Million
Q3 2020 Nov 04, 2020	SELL	$14.68 - $19.12 $53,420 - $69,577	-3,639 Reduced 5.93%	57,701 $1.07 Million
Q2 2020 Aug 05, 2020	SELL	$8.5 - $15.82 $169,269 - $315,039	-19,914 Reduced 24.51%	61,340 $848,000
Q1 2020 May 06, 2020	SELL	$7.25 - $19.22 $68,715 - $182,167	-9,478 Reduced 10.45%	81,254 $745,000
Q4 2019 Feb 07, 2020	BUY	$13.77 - $19.2 $37,123 - $51,763	2,696 Added 3.06%	90,732 $1.58 Million
Q3 2019 Nov 04, 2019	SELL	$14.93 - $19.83 $57,749 - $76,702	-3,868 Reduced 4.21%	88,036 $1.33 Million
Q2 2019 Aug 07, 2019	SELL	$15.01 - $18.89 $192,052 - $241,697	-12,795 Reduced 12.22%	91,904 $1.74 Million
Q1 2019 May 01, 2019	BUY	$16.23 - $20.29 $73,359 - $91,710	4,520 Added 4.51%	104,699 $1.83 Million
Q4 2018 Feb 04, 2019	BUY	$10.77 - $18.44 $264,629 - $453,089	24,571 Added 32.5%	100,179 $1.74 Million
Q3 2018 Oct 25, 2018	BUY	$9.1 - $14.8 $139,821 - $227,402	15,365 Added 25.51%	75,608 $1.07 Million
Q2 2018 Aug 02, 2018	BUY	$9.6 - $14.6 $578,332 - $879,547	60,243 New	60,243 $584,000

Others Institutions Holding VCEL

# of Institutions

276

Shares Held

48.8M

Call Options Held

91.8K

Put Options Held

23.2K

View Full List

About Vericel Corp

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.79B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

More about VCEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.

Account

Alps Advisors Inc Vericel Corp Transaction History